We work with private enterprises, conglomerates, and family groups to build R&D capability and deliver on their investments in scientific research.
Talk to UsA track record of betting early
Leading enterprises have built dedicated research capability remarkably early in their corporate history.
The competitive necessity
Corporate research is not aspirational. It's a necessary investment today, one that shapes what a company becomes tomorrow. Firms that neglect will lose relevance and see their value erode. These pressures aren't years away. It's here and amplified:
Restructuring, acquisitions, and operational excellence can buy a company time. Competitors copy each one eventually. Investment in research is the one lever that compounds instead of getting matched.
The Opportunity
Corporate R&D has emerged as the mainstream choice globally: it now draws more than half of all research spending. Three things make it the preferred model:
What starts as a founder's personal research program scales up into a full lab agenda. That transition can be managed to reduce development risk, deploy investment efficiently, and build in channels to tap value progressively.
Build real research capability. Invest early and deep. Manage a portfolio that stays stable even as strategy shifts. Run programs efficiently without losing speed. Translate what comes out of the lab into value for the company (new materials, processes, technologies, applications) and consumers (products, cost, reliability).
Research is not a cost-centre or philanthropy. It is just a different asset class, and managed actively it delivers extended value. Near term, that's new insights, tinkering, and spin-offs. Long term, it's the ability to anticipate and shape trends and technologies before competitors do.
Business enterprises have stepped up their spend on R&D significantly to build deep capability across a variety of emerging technologies. Investors value this as they expect revenue to grow more rapidly across different technologies and that these companies will have more pricing power. They recognise that R&D will generate intangible assets that are not fully captured in the books. The valuation premium shows willingness of markets to bet more on companies with greater R&D intensity.
Companies' value is increasingly in intangibles such as brands, capability, IP, data. This is now accelerated by AI. The old sources of competitive advantage offer less of a moat.
From ideation to concept, research mandate, business case, and development plan: for a new research facility, or for consolidating existing ones across the group.
Diagnostics identify what's blocking impact, from skill gaps to program management. Put in the right enablers (collaboration, autonomy, partnerships, digital tools). Value is captured through business engagement, IP strategy, commercialisation models.
Strategy for tech startups, deep-tech ventures, and university labs: turning disruptive ideas into markets that can actually grow.
Setting 5- to 10-year priorities and a roadmap to get there, and keeping the portfolio aligned to strategy and market relevance, so companies can adapt and take advantage of technological developments.
Today's strengths won't hold off disruption from across borders or industries for long. Buying in technology from labs or startups takes real work and gets expensive. Licensing or acquiring overseas comes with restrictions and dated terms. Building original research in-house is the most direct route to staying ahead.
A traditional corporate structure struggles to tap the right talent, back long bets, collaborate across boundaries, and carry a research mandate. A dedicated facility, with real autonomy, is what makes those choices possible.
Boards, protecting shareholder interests, want the capability to stay ahead of market and technology shifts. They also want proof that the spend on getting there is being watched and managed well.
Mature industries feel this most. Loyal customers are more willing to experiment, competitors keep testing new ways to stand out, and a ready ecosystem makes it cheap for newcomers to enter. A market leader who falls behind even briefly can lose share fast.
Research builds technical depth that pays off everywhere: better product design, faster absorption of new process technology, and higher standards across the board. It's what lets a company compete on more than cost or scale, since automation has made both easy to copy.
Our Difference
Built exclusively to design private-sector R&D. Most consulting firms build their practice around enterprise systems, outsourcing, or marketing. We build ours around one thing only.
End-to-end advisory across the full research lifecycle. From build-out or consolidation through strategy and portfolio management to realizing value at every stage, not only at the end.
Focused on the Indian context. We track the market and technology shifts that matter here, work with the local ecosystem as it actually is, and stay close to governance needs and national aspirations.
Decades of consulting experience. That experience spans restructuring entire sectors, designing markets and regulation, building platforms, and delivering national programs, always with a client focus and a long-term strategic perspective.
How We Work
We co-create the research mandate with you, then deliver it through your in-house teams, the talent already inside your walls, and the outside partners a focused firm knows how to bring in. No top-down advice, no playbook pulled off a shelf.
Read more about ResearchParcIf you're running a private industrial group and wish to shape your future through original research, this is the conversation to have.
Talk to Us